Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-02-28

FDA Approved: NARATRIPTAN — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic naratriptan product from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals) under an ANDA for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naratriptan (Naratriptan)

Snippet

ORIG AP for NARATRIPTAN (NARATRIPTAN)